Recommended

Somatostatin GPCR Assays

Background of Somatostatin Receptors

Somatostatin receptors are a group of G protein-coupled receptors with 5 subtypes, activated by their ligands, including endogenous peptides somatostatin-14 (SRIF-14), SRIF-28, cortistatin-17, (CST-17), and numerous synthetic ligands. SRIF-14, and SRIF-28 are the active fragments of precursor somatostatin, released from the hypothalamus. Somatostatin plays a wide range of biological roles in the regulation of multiple hormone releases, including neurotransmitters, growth hormones, thyroid-stimulating hormones, gastrointestinal hormones, pancreatic enzymes, and neuropeptides. In addition, somatostatin is involved in the inhibition of tumor cell proliferation.

Schematic drawing of the molecular interaction of SST and its analogs on G protein inhibitory. Fig.1 Schematic drawing of the molecular interaction of SST and its analogs on G protein inhibitory. (Abdellatif, 2018)

Distributions and Functions of Somatostatin Receptors

Somatostatin receptors are distributed throughout the brain and peripheral tissues. Except for SST4, other subtypes of somatostatin receptors have similar high affinities with SRIF-14 and SRIF-28. The activation of somatostatin receptors stimulates a vast array of intracellular signaling pathways, such as suppression of growth hormone release and regulation of neuronal activity. The agonists of those receptors are the general therapeutics used for the anti-secretion of neuroendocrine tumors.

Subtypes and Mechanisms of Somatostatin Receptors

Somatostatin receptors are a family of G protein-coupled receptors classified into 5 subtypes, including SST1, SST2, SST3, SST4, and SST5 receptors. Somatostatin receptors are found to couple pertussis toxin (PTX)-sensitive G-proteins.

Receptor Gene Mechanism Agonists Antagonists
SST1 receptor SSTR1
  • SST1 receptor binds to CST-17, SRIF-14, or SRIF-28 to promote signal transduction
  • SST1 receptor couples to Gi/Go protein, activating tyrosine phosphatases (PTPs) and regulating Na+/H+ exchanger
  • [125I]Tyr10-CST14
  • [125I]LTT-SRIF-28
  • [125I]Tyr11-SRIF-14
  • L-797,591
  • L-817,818
  • BIM 23052
  • CH 275
  • pasireotide
  • SRA880
  • BIM 23454
SST2 receptor SSTR2
  • SST2 receptor binds to CST-17, SRIF-14, or SRIF-28 to promote signal transduction
  • SST2 receptor couples to Gi/Go protein, inhibiting adenylyl cyclase
  • SST2 receptor couples to Gi/Go protein, activating the potassium channel while inhibiting calcium channel
  • SST2 receptor couples to Gi/Go protein in SST2-transfected CHO cells, activating ERK and PI3K
  • SST2 receptor inhibits phosphoinositide 3-kinase activity via direct molecular interactions between SST2 first intracellular loop and the regulatory PI3K p85 subunit or filamin-A
  • [125I]LTT-SRIF-28
  • [125I]Tyr10-CST14
  • [125I]Tyr3 SMS 201-995
  • L-054,522
  • L-779,976
  • SOM-230
  • KE 108
  • [D-Tyr8]CYN 154806
  • BASS antagonist
  • BIM 23627
  • BIM 23454
  • DOTA-JR11
SST3 receptor SSTR3
  • SST3 receptor binds to CST-17, SRIF-14, or SRIF-28 to promote signal transduction
  • SST3 receptor couples to Gi/Go protein, inhibiting adenylyl cyclase
  • [125I]Tyr10-CST14
  • [125I]LTT-SRIF-28
  • [125I]Tyr7-SST3-ODN-8
  • BN-81,644
  • BIM 23030
  • pasireotide
  • [111In]DOTA-BOC-ATE
  • ACQ090
  • MK-4256
  • SST3-ODN-8
SST4 receptor SSTR4
  • SST4 receptor binds to CST-17, SRIF-14, or SRIF-28 to promote signal transduction
  • SST4 receptor couples to Gi/Go protein, inhibiting adenylyl cyclase
  • SST4 receptor couples to Gi/Go protein, activating the potassium channel while inhibiting calcium channel
  • [125I]Tyr10-CST14
  • [125I]Tyr11-SRIF-14
  • [125I]LTT-SRIF-28
  • L-803,087
  • J-2156
  • veldoreotide
  • [L-Tyr8]CYN 154806
  • PRL-2915
  • BIM 23454
SST5 receptor SSTR5
  • SST5 receptor binds to CST-17, SRIF-14, or SRIF-28 to promote signal transduction
  • SST5 receptor couples to Gi/Go protein, inhibiting adenylyl cyclase and regulating potassium channel and calcium channel
  • [125I]LTT-SRIF-28
  • [125I]Tyr10-CST14
  • [125I]Tyr11-SRIF-14
  • L-817,818
  • BIM 23268
  • lanreotide
  • pasireotide
  • S5A1
  • BIM 23056

Assay List of Somatostatin Receptors

Creative Biolabs can provide a range of assays of somatostatin receptors. You can choose the assay in the list or contact us for more information:

SSTR1 SSTR2 SSTR3 SSTR4 SSTR5
Assay No. Assay Name Host Cell Assay Type Datasheet
Calcium Flux Assay
S01YF-0722-KX188 Magic™ Human SSTR1 In Vitro Calcium Assay, HEK293-Gα15 HEK293-Gα15 Calcium Flux Assay
[35S]GTPγS Binding Assay
S01YF-1122-KX943 Magic™ Human SSTR1 In Vitro [35S]GTPγS binding Assay CHO-K1 [35S]GTPγS binding Assay
Assay No. Assay Name Host Cell Assay Type Datasheet
cAMP Assay
S01YF-0722-KX52 Magic™ Human SSTR2 In Vitro Agonist cAMP Assay, HEK293 HEK293 cAMP Assay
S01YF-0722-KX191 Magic™ Rat SSTR2 In Vitro cAMP Assay, CHO-K1 CHO-K1 cAMP Assay
Calcium Flux Assay
S01YF-0722-KX189 Magic™ Human SSTR2 In Vitro Calcium Assay, HEK293-Gα15 HEK293-Gα15 Calcium Flux Assay
S01YF-1122-KX945 Magic™ Human SSTR2 In Vitro Calcium Flux Assay CHO-K1-Gα16 Calcium Flux Assay
[35S]GTPγS Binding Assay
S01YF-1122-KX947 Magic™ Human SSTR2 In Vitro [35S]GTPγS binding Assay CHO-K1 [35S]GTPγS binding Assay
Assay No. Assay Name Host Cell Assay Type Datasheet
Calcium Flux Assay
S01YF-0722-KX192 Magic™ Human SSTR3 In Vitro Calcium Assay, HEK293-Gα15 HEK293-Gα15 Calcium Flux Assay
S01YF-1122-KX949 Magic™ Human SSTR3 In Vitro Calcium Flux Assay CHO-K1-Gα16 Calcium Flux Assay
[35S]GTPγS Binding Assay
S01YF-1122-KX951 Magic™ Human SSTR3 In Vitro [35S]GTPγS binding Assay CHO-K1 [35S]GTPγS binding Assay
Assay No. Assay Name Host Cell Assay Type Datasheet
cAMP Assay
S01YF-0722-KX53 Magic™ Human SSTR4 In Vitro Agonist cAMP Assay, HEK293 HEK293 cAMP Assay
S01YF-1122-KX957 Magic™ Rat SSTR4 In Vitro cAMP Assay CHO-K1 cAMP Assay
Calcium Flux Assay
S01YF-0722-KX194 Magic™ Human SSTR4 In Vitro Calcium Assay, HEK293-Gα15 HEK293-Gα15 Calcium Flux Assay
S01YF-1122-KX953 Magic™ Human SSTR4 In Vitro Calcium Flux Assay CHO-K1-Gα16 Calcium Flux Assay
[35S]GTPγS Binding Assay
S01YF-1122-KX955 Magic™ Human SSTR4 In Vitro [35S]GTPγS binding Assay CHO-K1 [35S]GTPγS binding Assay
Assay No. Assay Name Host Cell Assay Type Datasheet
Calcium Flux Assay
S01YF-0722-KX196 Magic™ Human SSTR5 In Vitro Calcium Assay, HEK293-Gα15 HEK293-Gα15 Calcium Flux Assay
S01YF-1122-KX958 Magic™ Human SSTR5 In Vitro Calcium Flux Assay CHO-K1-Gα16 Calcium Flux Assay
[35S]GTPγS Binding Assay
S01YF-1122-KX959 Magic™ Human SSTR5 In Vitro [35S]GTPγS binding Assay CHO-K1 [35S]GTPγS binding Assay

Published Data

Paper Title Somatostatin venom analogs evolved by fish-hunting cone snails: From prey capture behavior to identifying drug leads.
Journal Science advances
Published 2022
Abstract Somatostatin (SS) is a peptide hormone that plays diverse roles in physiology. Taser-and-tether is one of the most widespread and best-studied fish-hunting strategies. The toxins were demonstrated to exert as biomedical drugs for diagnosing autoimmune disorders, as a fast-acting drug for treating diabetes and studying synaptic transmission, and the calcium channel blocker ω-conotoxin GVIA. The study investigated a deep-water clade of fish-hunting cone snails to find out that predator-prey generated multiple SS analogs, which could be taser-and-tether toxins for therapeutic applications, including pain, cancer, and endocrine disorders. Their findings proved that SS-like peptides were present in animal venoms, which provided a case study for the benefits of merging molecular phylogenetics with behavioral research to accelerate the identification of natural products with medicinal potential.
Result They observed the extremely slow onset of action of Consomatin Ro1 in mice suggesting that the venom of Asprella snails may contain toxins that target GPCRs expressed in the somatosensory or neuroendocrine systems of prey. Then they performed bioactivity-guided assays with an emphasis on compounds that elicited behavioral changes reminiscent of the slow-onset state of hypoactivity observed in fish after C. neocostatus envenomation, and screened Consomatin Ro1 against a panel of 318 human GPCRs. 10 μM Consomatin Ro1 activated SST4 and, to a lesser extent, SST1.

Fig.2. Consomatin Ro1 and G1 selectively activate the human SS receptors.Fig.2. Consomatin Ro1 and G1 selectively activate the human SS receptors. (Ramiro, 2022)

References

  1. Abdellatif, A.; et al. Somatostatin receptors as a new active targeting sites for nanoparticles. Saudi Pharmaceutical Journal. 2018, 26(7): 1051-1059.
  2. Ramiro, I. B. L.; et al. Somatostatin venom analogs evolved by fish-hunting cone snails: From prey capture behavior to identifying drug leads. Science advances. 2022, 8(12): eabk1410.
Note: All of our products are for Research Use Only (RUO). NOT intended for diagnostic, therapeutic or clinical use. We DO NOT offer patients any direct products or services. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry Send Inquiry
Inquiry Basket
compare

Go to compare